Actelion to host Company Update Conference Call / Audiocast
(Thomson Reuters ONE) -
Actelion Pharmaceuticals Ltd /
Actelion to host Company Update Conference Call / Audiocast
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Dear member of the investment community,
Actelion Ltd will host a Company Update in London on Tuesday, 08 May 2012, at
10.00 CEST/ 09.00 BST/ 4.00 a.m. EST.
The company will present an update on Actelion's strategy and business,
following the recent successful conclusion of the outcome study SERAPHIN with
macitentan in patients suffering from pulmonary arterial hypertension.
Present from Actelion will be:
Jean-Pierre Garnier (Chairman of the Board)
Jean-Paul Clozel (Chief Executive Officer)
Otto Schwarz (Chief Operating Officer)
Andrew Oakley (Chief Financial Officer)
The physical event (by invitation only to sell- and buy-side analysts) will be
web-casted as follows:
Date/Time:
08 May 2012 10.00 - 11.30 hrs Basel (CEST)
09.00 - 10.30 hrs UK (BST)
04.00 - 5.30 a.m. US (EST)
Conference Call Connect #:
Dial-in participants should start calling the number below 10-15 minutes before
the conference is due to start.
Dial: Europe: +41 (0)44 580 00 74
UK: +44 (0)203 367 94 53
US: +1 866 907 59 23
Participant's mode:
Listen-Only
Audiocast Access:
Audiocast participants should visit the Actelion website www.actelion.com 10-15
minutes before the conference is due to start.
If you experience any access problems go directly to the URL: http://view-
w.tv/p/120-121-11206/en
Participant's mode:
Listen only
Audiocast Replay:
The archived Investor Audiocast will be available for replay through
http://www.actelion.com approximately 60 minutes after the call has ended.
For further information please contact:
Roland Haefeli
Senior Vice President, Head of Investor Relations & Public
Affairs
+41 61 565 62 62
+1 646 737 49 72
http://www.actelion.com
Invitation PDF:
http://hugin.info/131801/R/1608128/510236.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Actelion Pharmaceuticals Ltd via Thomson Reuters ONE
[HUG#1608128]
Unternehmensinformation / Kurzprofil:
Datum: 02.05.2012 - 17:35 Uhr
Sprache: Deutsch
News-ID 141960
Anzahl Zeichen: 3089
contact information:
Town:
Allschwil
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 174 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Actelion to host Company Update Conference Call / Audiocast"
steht unter der journalistisch-redaktionellen Verantwortung von
Actelion Pharmaceuticals Ltd (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
